October 30, 2012

Iran Civil Society: From International Awards to Economic Suffering

This week in the review of civil society in Iran we mark the passing of religious scholar and political dissident Ahmad Ghabel and the award of […]
October 26, 2012

Sanctions: Who stole my medicine?

Arseh Sevom – The lives of six million patients in Iran are adversely affected due to shortages of medicine, as an immediate result of unprecedented sanctions. […]
October 22, 2012

Iran: Rationing, Gender Segregation, Executions

Economic instability continues to rock Iran while executions for drug offenses continue despite international protest. The work of children’s activists is recognized internationally, and gender segregation […]
October 15, 2012

Iran: Workers Unpaid, Sanctions Sting, Executions for Drug Offenses Up

Arseh Sevom’s weekly review has been offline for awhile, but now we are back. To share stories with us post email [email protected], share on our Facebook […]
October 10, 2012

Opposing Int’l Support for Drug Trafficking Prevention While the Death Penalty Exists for Drug-Related Offenses

We, the undersigned organizations, strongly oppose the continuing use of the death penalty in the Islamic Republic of Iran. We are concerned that Iran’s radical policies, which allegedly aim to eradicate drug-trafficking and result in the execution of several hundred prisoners every year, are supported in part by international funding. Of the countries that continue to apply the death penalty in their domestic jurisdictions, Iran leads in number of executions per capita. Many of these executions are conducted in secret and go unreported by official sources. According to reports from human rights groups that document executions in Iran from both official and unofficial sources, roughly 650 executions were carried out in 2010 and 670 in 2011. At the time of the publication of this statement, at least 332 individuals have been executed in 2012. Of these executions, it is estimated that more than 70% are for drug-related offenses.